About Impetigo* Skin INFECTIONS

 

ALTABAX treats impetigo skin infections* due to Staphylococcus aureus (methicillin-susceptible isolates only) and Streptococcus pyogenes, which are the two most common types of bacteria (germs) that cause this kind of infection.

Impetigo (impetigo contagiosa) is a highly contagious skin infection that mostly affects children. Children are especially susceptible to impetigo infections because their immune systems are still developing. Impetigo causes small, liquid-filled blisters that become a yellow crust. It’s common in warm, humid conditions and most often appears on the face and limbs. Impetigo spreads easily in schools and child care settings, as well as anywhere groups of people are in close contact. Crowding and poor personal hygiene can contribute to the spread of impetigo.1

If left untreated, impetigo can spread and cause serious or life-threatening diseases.2 Take this simple test and see your doctor if you are concerned that your skin infection may be impetigo.

For more information on skin infections, visit SkinInfection.com.

References:

  1. Baddour LM. Impetigo, folliculitis, furunculosis, and carbuncles. Available at: http://www.utdol.com. Accessed August 8, 2006.
  2. Group A Streptococcal (GAS) disease page. Centers for Disease Control and Prevention Web site. Available at: http://www.cdc.gov/ncidod/dbmd/diseaseinfo/Groupastreptococcal_g.htm. Accessed July 30, 2008.

Important Safety Information

*ALTABAX is indicated for use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo (up to 100 cm2 in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes.

The most common drug-related adverse reaction was application site irritation (1.4% of patients).

Please see complete Prescribing Information for ALTABAX
Please see additional information for consumers